New Retina Radio:

New Retina Radio Journal Club

New Retina Radio Journal Club

08.13.21

New Retina Radio Journal Club: Data in the Wake of COVID-19

As the threat of COVID-19 subsides, scientists are working to make sense of the information that was gathered during the pandemic. Caroline Baumal, MD, asks M. Ali Khan, MD; Vlad Matei, MD; and Christina Weng, MD, MBA, to tackle two papers that analyze data collected during this time. First, they address the strengths and limits of a paper from the infectious disease realm that used history of AMD as a marker for complement inhibition in patients with COVID-19. Then, they parse the details of an article reviewing how real-world high-frequency patients with wet AMD fared when treatment intervals were increased during the height of the pandemic. This editorially independent podcast is supported with advertising.

Watch This Episode as a Video

09.02.2021

New Retina Radio Journal Club: Data in the Wake of COVID-19

Caroline Baumal, MD; M. Ali Khan, MD; Vlad Matei, MD; and Christina Weng, MD, MBA

Other Podcast Episodes

07.18.25

Diabetic Retinopathy Severity and Income Status

Ben Young, MD; Phoebe Mellen, MD; and Jordan Deaner, MD

06.20.25

Photobiomodulation for Age-related Macular Degeneration

Moderator Barton Blackorby, MD; Hong-Uyen Hua, MD; and Louis Cai, MD

03.21.25

Rates of Ocular AEs After Faricimab Injection

Maura Di Nicola, MD; Sruthi Arepalli, MD; and Barton Blackorby, MD

12.19.24

Switching from Aflibercept to Faricimab in Wet AMD Patients

Ben Young, MD, MS; Lediana Goduni, MD; and Joshua Uhr, MD,

11.21.24

New Retina Radio Journal Club w/ VBS: Does Metformin Reduce AMD Risk?

Moderator Rebecca Soares, MD; Matt Starr, MD; and Nikisha Kothari, MD

09.17.24

New Retina Radio Journal Club w/ VBS: Risk of Death, Stroke, and MI After RAO

Katherine Talcott, MD; Kyle Kovacs, MD; and Phoebe Mellen, MD

Show More